Phase 4 Pancreatitis Trial, Recruiting (NCT07088757)

Phase 4 Pancreatitis Trial, Recruiting NCT07088757 Sponsor: Changhai Hospital Condition: Pancreatitis

Printed from Voxsanity (voxsanity.com.au) — NCT07088757 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pancreatitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older
You are scheduled to have a procedure called an ERCP (a procedure that uses a flexible camera and X-rays to examine and treat problems in the bile ducts and pancreas)

Who may not be able to join:

You have a medical reason why you cannot safely have an ERCP (confirm with trial site)
You are allergic to anti-inflammatory painkillers such as ibuprofen, naproxen, or similar medicines (known as NSAIDs)
You have taken anti-inflammatory painkillers (such as ibuprofen) within the last 7 days before the procedure
You have had bleeding in your stomach or gut within the last 4 weeks, have reduced kidney function, or have a blood clotting problem
You have had pancreatitis (inflammation of the pancreas) within the 3 days before your scheduled procedure
Your blood pressure or circulation is currently unstable
You are pregnant or currently breastfeeding
You are not willing or not able to give your signed agreement to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: +8613817593520

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07088757

Sponsor: Changhai Hospital

Phase: Phase 4

Status: Recruiting

Condition: Pancreatitis

Trial contact: +8613817593520

More information: https://clinicaltrials.gov/study/NCT07088757

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older
You are scheduled to have a procedure called an ERCP (a procedure that uses a flexible camera and X-rays to examine and treat problems in the bile ducts and pancreas)

Who may not be able to join:

You have a medical reason why you cannot safely have an ERCP (confirm with trial site)
You are allergic to anti-inflammatory painkillers such as ibuprofen, naproxen, or similar medicines (known as NSAIDs)
You have taken anti-inflammatory painkillers (such as ibuprofen) within the last 7 days before the procedure
You have had bleeding in your stomach or gut within the last 4 weeks, have reduced kidney function, or have a blood clotting problem
You have had pancreatitis (inflammation of the pancreas) within the 3 days before your scheduled procedure
Your blood pressure or circulation is currently unstable
You are pregnant or currently breastfeeding
You are not willing or not able to give your signed agreement to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Changhai Hospital

Registry

ClinicalTrials.gov

Start date

15 September 2025

Est. completion

1 November 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The Proportion of Subjects in Each Study Group With Post-ERCP Pancreatitis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov